Professional
Added to YB: 2026-03-23
Pitch date: 2026-03-19
VREOF [neutral]
Vireo Growth Inc.
Author Info
Mindset Value provides deep dive research into publicly traded stocks, business models, and ideas. Sign up for the newsletter.
Company Info
Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah.
Market Cap
CAD 472.7M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
29.16
P/E
-3.65
EV/Sales
3.06
Sector
Pharmaceuticals
Category
growth
A Vireo Strong Quarter
VREOF (earnings): Q4 rev $105M (+25% pro forma), beat est by 10%+, 11.3% same-store sales growth. Outperformed in mature markets: NV +12% vs market +2%, MO +7% vs +2%. 4 acquisitions pending could add $400M+ rev at <5x EBITDA, targeting $800-900M total rev (top 5 globally). MN facility near completion, supply-constrained for years. $100M+ cash. Stock trades 4-5x EBITDA despite double-digit growth trajectory.
Read full article (3 min)